Tourmaline Bio Stock Analysis

Tourmaline Stock Analysis Notes

About 22.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tourmaline Bio recorded a loss per share of 3.23. The entity last dividend was issued on the 20th of October 2023. The firm had 1:10 split on the 20th of October 2023. To find out more about Tourmaline Bio contact Sandeep MD at 646 481 9832 or learn more at https://www.tourmalinebio.com.

Tourmaline Bio Investment Alerts

Tourmaline Bio Upcoming and Recent Events

Tourmaline Largest EPS Surprises

View All Earnings Estimates

Tourmaline Bio Environmental, Social, and Governance (ESG) Scores

Tourmaline Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 474.72 M.

Tourmaline Profitablity

Management Efficiency

Tourmaline Bio has return on total asset (ROA) of (0.1903) % which means that it has lost $0.1903 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2614) %, meaning that it created substantial loss on money invested by shareholders. Tourmaline Bio's management efficiency ratios could be used to measure how well Tourmaline Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.25. The value of Return On Capital Employed is expected to slide to -0.31. At this time, Tourmaline Bio's Total Assets are quite stable compared to the past year. Non Current Assets Total is expected to rise to about 42.2 M this year, although the value of Debt To Assets will most likely fall to 0.0008.

Technical Drivers

As of the 20th of July, Tourmaline Bio has the Semi Deviation of 3.33, coefficient of variation of 782.63, and Risk Adjusted Performance of 0.1269. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tourmaline Bio, as well as the relationship between them. Please validate Tourmaline Bio jensen alpha and downside variance to decide if Tourmaline Bio is priced more or less accurately, providing market reflects its prevalent price of 18.48 per share. Given that Tourmaline Bio has jensen alpha of 0.3949, we advise you to double-check Tourmaline Bio's current market performance to make sure the company can sustain itself at a future point.

Tourmaline Bio Price Movement Analysis

Tourmaline Bio Insider Trading Activities

Tourmaline Bio Outstanding Bonds

Tourmaline Bio Predictive Daily Indicators

Tourmaline Bio Corporate Filings

Tourmaline Bio Forecast Models

Tourmaline Bio's time-series forecasting models are one of many Tourmaline Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tourmaline Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tourmaline Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tourmaline shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tourmaline Bio. By using and applying Tourmaline Stock analysis, traders can create a robust methodology for identifying Tourmaline entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tourmaline analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tourmaline analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tourmaline Bio stock analysis indicators help investors evaluate how Tourmaline Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tourmaline Bio shares will generate the highest return on investment. By understating and applying Tourmaline Bio stock analysis, traders can identify Tourmaline Bio position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.